Health Condition 1: null- Epistaxis during nasotracheal intubation
Conditions
Interventions
Intervention1: xylometazoline: 0.6ml/3 drops of 0.1% xylometazoline nasal drops will be instilled in both the nostrils of the patient. Anaesthesiologist ,performing the intubation will comment on the
Sponsors
Postgraduate institute of medical education and research
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and ASA 2 patients with normal coagulation profile requiring nasal intubation for any surgery of duration upto 4hours.
Exclusion criteria
Exclusion criteria: 1.H/O cough and cold in past two weeks 2.Patients taking any oral decongestants, nonsteroidal inflammatory drugs(NSAIDS) or anti histamines 3.H/O nasal deformity or nasal trauma 4.H/O recurrent epistaxis, known allergy to used drugs 5.Patients with dearanged liver function profile 6.Pregnancy 7.Uncontrolled hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To see the presence and scale of bleeding due to NTI using xylometazoline nasal drops versus epinephrine merocel nasal pack. Timepoint: 30 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To see the presence of bleeding during extubation. 2.To assess the navigability through the nasal passage 3.To assess post operative patient comfort level in terms of difficulty in nasal breathing or nasal pain,any nasal trauma or persistent nasal bleeding. Timepoint: 1 hour | — |
Countries
India
Contacts
Public ContactSonam Patel
Postgraduate institute of medical education and research
Outcome results
None listed